Mill Creek Capital Advisors, LLC

Position in ADAG — Adagene Inc.

CIK 1964962 Conshohocken, PA

Position in ADAG

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$782,471

+$405,209 QoQ

Shares Held

199,610

0.0% QoQ

Ownership

0.302%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mill Creek Capital Advisors, LLC holds $2,260,246 across 4 Biotechnology names. ADAG ranks #1 (34.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADAG	Adagene Inc. This page	199,610	$782,471
2	SRRK	Scholar Rock Holding Corp	12,664	$622,562
3	PGEN	Precigen, Inc.	150,150	$581,080
4	CNTX	Context Therapeutics Inc.	104,631	$274,133

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$782,471	199,610	0.0%	Shares	Sole	2026-05-14
2025-12-31	$377,262	199,610	0.0%	Shares	Sole	2026-02-13
2025-09-30	$397,223	199,610	0.0%	Shares	Sole	2025-11-12
2025-06-30	$389,239	199,610	0.0%	Shares	Sole	2025-08-11
2025-03-31	$303,407	199,610	0.0%	Shares	Sole	2025-05-13
2024-12-31	$397,223	199,610	+119.6%	Shares	Sole	2025-01-29
2024-09-30	$201,815	90,908	—	Shares	Sole	2024-11-06
No filing history on record for this holder in this stock.